{"id":20288,"date":"2022-09-29T08:28:54","date_gmt":"2022-09-29T12:28:54","guid":{"rendered":"https:\/\/medicarereport.org\/?p=20288"},"modified":"2022-09-29T08:28:56","modified_gmt":"2022-09-29T12:28:56","slug":"an-alzheimers-therapy-scores-winning-results-but-what-could-it-mean-for-patients","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=20288","title":{"rendered":"An Alzheimer\u2019s therapy scores winning results, but what could it mean for patients?"},"content":{"rendered":"\n<p>(By Andrew Joseph for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>The news Tuesday night that a clinical trial of an experimental Alzheimer\u2019s therapy had succeeded hit like a blast \u2014 at last, a rare win in a disease devastating nearly 6 million Americans and countless more caregivers.  Continue reading <a href=\"https:\/\/www.statnews.com\/2022\/09\/28\/lecanumab-alzheimers-half-point-gain-meaning-for-patents\/\" data-type=\"URL\" data-id=\"https:\/\/www.statnews.com\/2022\/09\/28\/lecanumab-alzheimers-half-point-gain-meaning-for-patents\/\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"32\" class=\"wp-image-4372\" style=\"width: 300px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Andrew Joseph for STAT) The news Tuesday night that a clinical trial of an experimental Alzheimer\u2019s therapy had succeeded<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,15],"tags":[116],"class_list":["post-20288","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-part-dprescription-drugs","tag-alzheimers-disease"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20288"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20288\/revisions"}],"predecessor-version":[{"id":20289,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20288\/revisions\/20289"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}